Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus.

Literature DB >> 20542181

Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus.

Peter Arne Gerber, Bettina Alexandra Buhren, Ferda Cevikbas, Edwin Bölke, Martin Steinhoff, Bernhard Homey.

Abstract

Entities: Disease Gene

Mesh：

Substances：
ErbB Receptors

Year: 2010 PMID： 20542181 DOI： 10.1016/j.jaad.2009.09.023

Source DB: PubMed Journal: J Am Acad Dermatol ISSN： 0190-9622 Impact factor: 11.527

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

Review 1. Rosacea: The cytokine and chemokine network.

Authors: Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal: J Investig Dermatol Symp Proc Date: 2011-12

2. Mechanisms of skin aging induced by EGFR inhibitors.

Authors: Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Peter Hevezi; Edwin Bölke; Dennis Sohn; Reiner U Jänicke; Viswanath Reddy Belum; Caroline Robert; Mario E Lacouture; Bernhard Homey
Journal: Support Care Cancer Date: 2016-05-10 Impact factor: 3.603

3. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.

Authors: Viswanath Reddy Belum; Courtney Washington; Christine A Pratilas; Vincent Sibaud; Franck Boralevi; Mario E Lacouture
Journal: Pediatr Blood Cancer Date: 2015-02-12 Impact factor: 3.167

4. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Authors: Peter Arne Gerber; Stephan Meller; Tatiana Eames; Bettina Alexandra Buhren; Holger Schrumpf; Sonja Hetzer; Laura Maximiliane Ehmann; Wilfried Budach; Edwin Bölke; Christiane Matuschek; Andreas Wollenberg; Bernhard Homey
Journal: Eur J Med Res Date: 2012-02-23 Impact factor: 2.175

Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus.

Review 1. Rosacea: The cytokine and chemokine network.

2. Mechanisms of skin aging induced by EGFR inhibitors.

3. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis.

4. Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients.

Review 5. [Cutaneous side effects of targeted cancer drugs].

6. Tissue-specific contributions of Tmem79 to atopic dermatitis and mast cell-mediated histaminergic itch.

Review 7. Pruritus in patients treated with targeted cancer therapies: systematic review and meta-analysis.

Review 8. Dermatological adverse events from BRAF inhibitors: a growing problem.

Review 9. [Drug reactions caused by chemotherapy agents].

10. Comparison of gefitinib-induced skin adverse reactions (SAR) in C57BL/6 and FVB/N mice.